2 unknown, 1 completed, 1 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Peripheral Nerve Injuries: new trials by email Literature Review of Peripheral Nerve Injuries trials Research Report on Peripheral Nerve Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. NTX-001 (PEG-Fusion) - Peripheral Nerve Injury Upper Limb, Peripheral Nerve Injury (PNI) | Phase 3 | Recruiting | Neuraptive Therapeutics Inc. | 98 | 2025-02-10 | 2026-10-06 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration. Electrical Stimulation, Sham Stimulation - Peripheral Nerve Injuries, Sensory Deficit | Phase 2 / Phase 3 | Completed | University of Alberta | 38 | 2017-10-01 | 2024-09-19 |
Agnosia (2) · Chronic Pain (2) · Marijuana Abuse (2) · Neuralgia (2) · Pain (2) · Pain, Postoperative (2) · Peripheral Nervous System Diseases (2) · Somatoform Disorders (2)
Nervous System Diseases (4) · Neuromuscular Diseases (4) · Trauma, Nervous System (4) · Wounds and Injuries (4) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Perceptual Disorders (2) · Peripheral Nervous System Diseases (2) · Postoperative Complications (2) · Signs and Symptoms (2) · Substance-Related Disorders (2)
Apurano Pharmaceuticals GmbH (2) · Neuraptive Therapeutics Inc. (1) · University of Alberta (1)
Germany (2) · Canada (1) · United States (1)
Julie Beveridge, MD (1) · K Ming Chan, MB ChB (1) · Seth Schulman, MD (1)